Literature DB >> 29379189

Cancer immunotherapy in 2017: The breakthrough of the microbiota.

Guido Kroemer1, Laurence Zitvogel2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29379189     DOI: 10.1038/nri.2018.4

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  11 in total

1.  Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

Authors:  Vinod P Balachandran; Marta Łuksza; Julia N Zhao; Vladimir Makarov; John Alec Moral; Romain Remark; Brian Herbst; Gokce Askan; Umesh Bhanot; Yasin Senbabaoglu; Daniel K Wells; Charles Ian Ormsby Cary; Olivera Grbovic-Huezo; Marc Attiyeh; Benjamin Medina; Jennifer Zhang; Jennifer Loo; Joseph Saglimbeni; Mohsen Abu-Akeel; Roberta Zappasodi; Nadeem Riaz; Martin Smoragiewicz; Z Larkin Kelley; Olca Basturk; Mithat Gönen; Arnold J Levine; Peter J Allen; Douglas T Fearon; Miriam Merad; Sacha Gnjatic; Christine A Iacobuzio-Donahue; Jedd D Wolchok; Ronald P DeMatteo; Timothy A Chan; Benjamin D Greenbaum; Taha Merghoub; Steven D Leach
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

2.  Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer.

Authors:  Susan Bullman; Chandra S Pedamallu; Ewa Sicinska; Thomas E Clancy; Xiaoyang Zhang; Diana Cai; Donna Neuberg; Katherine Huang; Fatima Guevara; Timothy Nelson; Otari Chipashvili; Timothy Hagan; Mark Walker; Aruna Ramachandran; Begoña Diosdado; Garazi Serna; Nuria Mulet; Stefania Landolfi; Santiago Ramon Y Cajal; Roberta Fasani; Andrew J Aguirre; Kimmie Ng; Elena Élez; Shuji Ogino; Josep Tabernero; Charles S Fuchs; William C Hahn; Paolo Nuciforo; Matthew Meyerson
Journal:  Science       Date:  2017-11-23       Impact factor: 47.728

3.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.

Authors:  TaChung Yu; Fangfang Guo; Yanan Yu; Tiantian Sun; Dan Ma; Jixuan Han; Yun Qian; Ilona Kryczek; Danfeng Sun; Nisha Nagarsheth; Yingxuan Chen; Haoyan Chen; Jie Hong; Weiping Zou; Jing-Yuan Fang
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

4.  Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Authors:  Leore T Geller; Michal Barzily-Rokni; Tal Danino; Oliver H Jonas; Noam Shental; Deborah Nejman; Nancy Gavert; Yaara Zwang; Zachary A Cooper; Kevin Shee; Christoph A Thaiss; Alexandre Reuben; Jonathan Livny; Roi Avraham; Dennie T Frederick; Matteo Ligorio; Kelly Chatman; Stephen E Johnston; Carrie M Mosher; Alexander Brandis; Garold Fuks; Candice Gurbatri; Vancheswaran Gopalakrishnan; Michael Kim; Mark W Hurd; Matthew Katz; Jason Fleming; Anirban Maitra; David A Smith; Matt Skalak; Jeffrey Bu; Monia Michaud; Sunia A Trauger; Iris Barshack; Talia Golan; Judith Sandbank; Keith T Flaherty; Anna Mandinova; Wendy S Garrett; Sarah P Thayer; Cristina R Ferrone; Curtis Huttenhower; Sangeeta N Bhatia; Dirk Gevers; Jennifer A Wargo; Todd R Golub; Ravid Straussman
Journal:  Science       Date:  2017-09-15       Impact factor: 47.728

5.  Mining the Human Gut Microbiota for Immunomodulatory Organisms.

Authors:  Naama Geva-Zatorsky; Esen Sefik; Lindsay Kua; Lesley Pasman; Tze Guan Tan; Adriana Ortiz-Lopez; Tsering Bakto Yanortsang; Liang Yang; Ray Jupp; Diane Mathis; Christophe Benoist; Dennis L Kasper
Journal:  Cell       Date:  2017-02-16       Impact factor: 41.582

Review 6.  Anticancer effects of the microbiome and its products.

Authors:  Laurence Zitvogel; Romain Daillère; María Paula Roberti; Bertrand Routy; Guido Kroemer
Journal:  Nat Rev Microbiol       Date:  2017-05-22       Impact factor: 60.633

7.  Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

Authors:  Jonathan U Peled; Sean M Devlin; Anna Staffas; Melissa Lumish; Raya Khanin; Eric R Littmann; Lilan Ling; Satyajit Kosuri; Molly Maloy; John B Slingerland; Katya F Ahr; Kori A Porosnicu Rodriguez; Yusuke Shono; Ann E Slingerland; Melissa D Docampo; Anthony D Sung; Daniela Weber; Amin M Alousi; Boglarka Gyurkocza; Doris M Ponce; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Ying Taur; Eric G Pamer; Robert R Jenq; Marcel R M van den Brink
Journal:  J Clin Oncol       Date:  2017-03-15       Impact factor: 44.544

8.  Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Authors:  V Gopalakrishnan; C N Spencer; L Nezi; A Reuben; M C Andrews; T V Karpinets; P A Prieto; D Vicente; K Hoffman; S C Wei; A P Cogdill; L Zhao; C W Hudgens; D S Hutchinson; T Manzo; M Petaccia de Macedo; T Cotechini; T Kumar; W S Chen; S M Reddy; R Szczepaniak Sloane; J Galloway-Pena; H Jiang; P L Chen; E J Shpall; K Rezvani; A M Alousi; R F Chemaly; S Shelburne; L M Vence; P C Okhuysen; V B Jensen; A G Swennes; F McAllister; E Marcelo Riquelme Sanchez; Y Zhang; E Le Chatelier; L Zitvogel; N Pons; J L Austin-Breneman; L E Haydu; E M Burton; J M Gardner; E Sirmans; J Hu; A J Lazar; T Tsujikawa; A Diab; H Tawbi; I C Glitza; W J Hwu; S P Patel; S E Woodman; R N Amaria; M A Davies; J E Gershenwald; P Hwu; J E Lee; J Zhang; L M Coussens; Z A Cooper; P A Futreal; C R Daniel; N J Ajami; J F Petrosino; M T Tetzlaff; P Sharma; J P Allison; R R Jenq; J A Wargo
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

9.  Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Authors:  Bertrand Routy; Emmanuelle Le Chatelier; Lisa Derosa; Connie P M Duong; Maryam Tidjani Alou; Romain Daillère; Aurélie Fluckiger; Meriem Messaoudene; Conrad Rauber; Maria P Roberti; Marine Fidelle; Caroline Flament; Vichnou Poirier-Colame; Paule Opolon; Christophe Klein; Kristina Iribarren; Laura Mondragón; Nicolas Jacquelot; Bo Qu; Gladys Ferrere; Céline Clémenson; Laura Mezquita; Jordi Remon Masip; Charles Naltet; Solenn Brosseau; Coureche Kaderbhai; Corentin Richard; Hira Rizvi; Florence Levenez; Nathalie Galleron; Benoit Quinquis; Nicolas Pons; Bernhard Ryffel; Véronique Minard-Colin; Patrick Gonin; Jean-Charles Soria; Eric Deutsch; Yohann Loriot; François Ghiringhelli; Gérard Zalcman; François Goldwasser; Bernard Escudier; Matthew D Hellmann; Alexander Eggermont; Didier Raoult; Laurence Albiges; Guido Kroemer; Laurence Zitvogel
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

10.  A single-cell survey of the small intestinal epithelium.

Authors:  Adam L Haber; Moshe Biton; Noga Rogel; Rebecca H Herbst; Karthik Shekhar; Christopher Smillie; Grace Burgin; Toni M Delorey; Michael R Howitt; Yarden Katz; Itay Tirosh; Semir Beyaz; Danielle Dionne; Mei Zhang; Raktima Raychowdhury; Wendy S Garrett; Orit Rozenblatt-Rosen; Hai Ning Shi; Omer Yilmaz; Ramnik J Xavier; Aviv Regev
Journal:  Nature       Date:  2017-11-08       Impact factor: 49.962

View more
  40 in total

1.  Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade.

Authors:  Bo Ryeong Lee; Sehyun Chae; Jihyun Moon; Myeong Joon Kim; Hankyu Lee; Hyuk Wan Ko; Byoung Chul Cho; Hyo Sup Shim; Daehee Hwang; Hye Ryun Kim; Sang-Jun Ha
Journal:  JCI Insight       Date:  2020-07-23

Review 2.  Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer.

Authors:  Nicholas Borcherding; Ryan Kolb; Jodi Gullicksrud; Praveen Vikas; Yuwen Zhu; Weizhou Zhang
Journal:  J Mol Biol       Date:  2018-05-22       Impact factor: 5.469

Review 3.  Strategies for Predicting Response to Checkpoint Inhibitors.

Authors:  Roberta Zappasodi; Jedd D Wolchok; Taha Merghoub
Journal:  Curr Hematol Malig Rep       Date:  2018-10       Impact factor: 3.952

4.  Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking.

Authors:  Kieng B Vang; Ruud P M Dings; Samir V Jenkins; Michael S Robeson; Robert J Griffin; Charles M Quick; Eric R Siegel; Martin J Cannon
Journal:  Cancer Res       Date:  2019-10-07       Impact factor: 12.701

Review 5.  Redrawing therapeutic boundaries: microbiota and cancer.

Authors:  Jonathan Sholl; Gregory D Sepich-Poore; Rob Knight; Thomas Pradeu
Journal:  Trends Cancer       Date:  2021-11-26

Review 6.  Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy.

Authors:  Su-Ran Li; Fang-Yi Huo; Han-Qi Wang; Jing Wang; Chun Xu; Bing Liu; Lin-Lin Bu
Journal:  J Nanobiotechnology       Date:  2022-06-14       Impact factor: 9.429

7.  Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.

Authors:  Dae Hee Pyo; Hye Kyung Hong; Woo Yong Lee; Yong Beom Cho
Journal:  Cancer Biol Ther       Date:  2020-03-25       Impact factor: 4.742

Review 8.  [Predictive value of PD-L1 diagnostics].

Authors:  H-U Schildhaus
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

Review 9.  Multi-omics data integration considerations and study design for biological systems and disease.

Authors:  Stefan Graw; Kevin Chappell; Charity L Washam; Allen Gies; Jordan Bird; Michael S Robeson; Stephanie D Byrum
Journal:  Mol Omics       Date:  2021-04-19

Review 10.  Immune Escape during Breast Tumor Progression.

Authors:  Carlos R Gil Del Alcazar; Maša Alečković; Kornelia Polyak
Journal:  Cancer Immunol Res       Date:  2020-04       Impact factor: 12.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.